Have a personal or library account? Click to login
Open Access
|Apr 2022

References

  1. 1. Child Development Institute. Allergies in Adolescents. [Internet]. Available from: https://childdevelopmentinfo.com/child-teen-health/diseases-conditions/allergies-adolescents/#.WLbPmtLygdU. Accessed March 1, 2017.
  2. 2. Halken S. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol. 2004;15 Suppl 16:4-5, 9-32. DOI: 10.1111/j.1399-3038.2004.0148b.x.
  3. 3. Kaila M, Rautava P, Holmberg-Marttila D, Vahlberg T, Aromaa M, Sillanpaa M. Allergy from infancy to adolescence. A population-based 18-years follow-up cohort. BMC Pediatr. 2009;9:46. DOI: 10.1186/1471-2431-9-46.
  4. 4. Kajosaari M. Food allergy in Finnish children aged 1 to 6 years. Acta Paediatr Scand. 1982;71(5):815-9. DOI: 10.1111/j.1651-2227.1982.tb09525.x.
  5. 5. Limb SL, Brown KC, Wood RA, Wise RA, Eggleston PA, Tonascia J, et al. Adult asthma severity in individuals with a history of childhood asthma. J Allergy Clin Immunol. 2005;115(1):61-6. DOI: 10.1016/j. jaci.2004.09.032.
  6. 6. Peat JK, Salome CM, Sedgwick CS, Kerrebijn J, Woolcock AJ. A prospective study of bronchial hyperresponsiveness and respiratory symptoms in a population of Australian schoolchildren. Clin Exp Allergy. 1989;19(3):299-306. DOI: 10.1111/j.1365-2222.1989.tb02387.x.
  7. 7. Nickel R, Kulig M, Forster J, Bergmann R, Bauer CP, Lau S, et al. Sensitisation to hen’s egg at the age of twelve months is predictive for allergic sensitisation to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol. 1997;99(5):613-7. DOI: 10.1016/s0091-6749(97)70021-6.
  8. 8. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Eng J Med. 1995;332(3):133-8. DOI: 10.1056/NEJM199501193320301.
  9. 9. Arshad SH. Primary prevention of asthma and allergy. J Allergy Clin Immunol. 2005;116(1):3-14; quiz 15. DOI: 10.106/j.jaci.2005.03.043.
  10. 10. Von Mutius E. Paediatric origins of adult lung disease. Thorax. 2001;56(2):153-7. DOI: 10.1136/thorax.56.2.153.
  11. 11. Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ. Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol. 2001;108(5):720-5. DOI: 10.1067/mai.2001.119151.
  12. 12. Beasly R, The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351(9111):1225-32. DOI: 10.1016/S0140-6736(97)07302-9.
  13. 13. Lehtonen EPM, Holmberg-Marttila D, Kaila M. Cumulative prevalence of atopic eczema and related skin symptoms in a well-baby clinic: a retrospective cohort study. Pediatr Allergy Immunol. 2003;14(5):405-8. DOI: 10.1034/j.1399-3038.2003.00071.x.
  14. 14. Eggesbø M, Halvorsen R, Tambs K, Botten G. Prevalence of parentally perceived adverse reactions to food in young children. Pediatr Allergy Immunol. 1999;10(2):122-32. DOI: 10.1034/j.1399-3038.1999.00022.x.
  15. 15. Saarinen KM, Juntunen-Backman K, Järvenpää AL, Kuitunen P, Lope L, Renlund M, et al. Supplementary feeding in maternity hospitals and the risk of cow’s milk allergy: A prospective study of 6209 infants. J Allergy Clin Immunol. 1999;104(2 Pt 1):457-61. DOI: 10.1016/s0091-6749(99)70393-3.
  16. 16. Host A. Frequency of cow’s milk allergy in childhood. Ann Allergy Asthma Immunol. 2002;89(6 Suppl 1):33-7. DOI: 10.1016/s1081-1206(10)62120-5.
  17. 17. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics. 1987;79(5):683-8.
  18. 18. Vasar M, Julge K, Bjoksto B. Development of atopic sensitization and allergic diseases in early childhood. Acta Paediatr. 2000;89(5):523-7. DOI: 10.1080/080352500750027781.
  19. 19. Jogi R, Janson C, Björnsson E, Boman G, Björkstén B. Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy. 1998;28(9):1072-80. DOI: 10.1046/j.1365-2222.1998.00366.x.
  20. 20. Huurre TM, Aro HM, Jaakkola JJ. Incidence and prevalence of asthma and allergic rhinitis: a cohort study of Finnish adolescents. J Asthma. 2004;41(3):311-7. DOI: 10.1081/jas-120026088.
  21. 21. Hansen TE, Evjenth B, Holt J. Increasing prevalence of asthma, allergic rhino-conjunctivitis and eczema among school children: three surveys during the period 1985-2008. Acta Paediatr. 2013;102(1):47-52. DOI: 10.1111/apa.12030.
  22. 22. McNeill G, Tagiyeva N, Aucott L, Russell G, Helms PJ. Changes in the prevalence of asthma, eczema and hay fever in pre-pubertal children: a 40-year perspective. Paediatr Perinat Epidemiol. 2009;23(6):506-12. DOI: 10.1111/j.1365-3016.2009.01057.x.
  23. 23. Solé D, Filho NAR, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012). J Pediatr (Rio J). 2015;91(1):30-5. DOI: 10.1016/j.jped.2014.05.002.
  24. 24. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-43. DOI: 10.1016/S0140-6736(06)69283-0.
  25. 25. de Benedictis D, Bush A. The challenge of asthma in adolescence. Pediatr Pulmonol. 2007;42(8):683-92. DOI: 10.1002/ppul.20650.
  26. 26. Katon WJ, Richardson L, Lozano P, McCauley E. The relationship of asthma and anxiety disorders. Psychosom Med. 2004;66(3):349-55. DOI: 10.1097/01.psy.0000126202.89941.ea.
  27. 27. Erge D, Uysal P, Aksu H, Avcil S, Özgür BG, Demir F, et al. Psychological status of adolescents with respiratory allergic diseases and their caregivers. Meandros Med Dent J. 2016;17:120-8.
  28. 28. Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, et al. Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12–14 year olds in the British Isles, 1995–2002: questionnaire survey. BMJ. 2004;328(7447):1052-3. DOI: 10.1136/bmj.38057.583727.47.
  29. 29. Braun-Fahrlander C, Gassner M, Grize L, Takken-Sahli K, Neu U, Stricker T, et al. No further increase in asthma, hay fever and atopic sensitization in adolescents living in Switzerland. Eur Respir J. 2004;23(3):407-13. DOI: 10.1183/09031936.04.00074004.
  30. 30. Galassi C, De Sario M, Biggeri A, Bisanti L, Chellini E, Ciccone G, et al. Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994–2002. Pediatrics. 2006;117(1):34-42. DOI: 10.1542/peds.2004-2709.
  31. 31. de Marco R, Locatelli F, Sunyer J, Burney P. Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med. 2000;162(1):68-74. DOI: 10.1164/ajrccm.162.1.9907008.
  32. 32. von Mutius E. Progression of allergy and asthma through childhood to adolescence. Thorax. 1996;51(Suppl 1):S3-S6. DOI: 10.1136/thx.51.suppl_1.s3.
  33. 33. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964–1999. J Allergy Clin Immunol. 2002;109(2):189-94. DOI: 10.1067/mai.2002.120951.
  34. 34. Mannino DM, Homa DM, Redd SC. Involuntary smoking and asthma severity in children: data from the Third National Health and Nutrition Examination Survey. Chest. 2002;122(2):409-15. DOI: 10.1378/chest.122.2.409.
  35. 35. Couriel J. Asthma in adolescence. Paediatr Respir Rev. 2003;4(1):47-54. DOI: 10.1016/s1526-0542(02)00309-3.
  36. 36. Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med. 2005;172(10):1253-8. DOI: 10.1164/rccm.200504-252OC.
  37. 37. Xuan W, Marks G, Toelle B, Belousova E, Peat JK, Berry G, et al. Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax. 2002;57(2):104-9. DOI: 10.1136/thorax.57.2.104.
  38. 38. de Benedictis FM, Canny GJ, Levison H. The progressive natural history of childhood asthma. Lung. 1990;168 Suppl:278-85. DOI: 10.1007/BF02718143.
  39. 39. Pité H, Gaspar Â, Morais-Almeida M. Preschool-age wheezing phenotypes and asthma persistence in adolescents. Allergy Asthma Proc. 2016;37(3):231-41. DOI: 10.2500/aap.2016.37.3955.
  40. 40. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414-22. DOI: 10.1056/NEJMoa022363.
  41. 41. Ulrik SC, Backer V. Markers of impaired growth of pulmonary function in children and adolescents. Am J Respir Crit Care Med. 1999;160(1):40-4. DOI: 10.1164/ajrccm.160.1.9806059.
  42. 42. Mandhane PJ, Greene JM, Cowan JO, Taylor DR, Sears MR. Sex differences in factors associated with childhood and adolescent - onset wheeze. Am J Respir Crit Care Med. 2005;172(1):45-54. DOI: 10.1164/rccm.200412-1738OC.
  43. 43. Tantisira KG, Weiss ST. Complex interactions in complex traits: obesity and asthma. Thorax. 2001;56 Suppl 2(Suppl 2):ii64-73.
  44. 44. Becklake M, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax. 1999;54(12):1119-38. DOI: 10.1136/thx.54.12.1119.
  45. 45. Holmen TL, Barrett-Connor E, Holmen J, Bjermer L. Health problems in teenage daily smokers versus nonsmokers, Norway, 1995– 1997: The Nord-Trondelag Health Study. Am J Epidemiol. 2000;151(2):148-55. DOI: 10.1093/oxfordjournals.aje.a010182.
  46. 46. Venn A, Lewis S, Cooper M, Hill J, Britton J. Questionnaire study of effect of sex and age on the prevalence of wheeze and asthma in adolescence. BMJ. 1998;316(7149):1945-6. DOI: 10.1136/bmj.316.7149.1945.
  47. 47. Kuhni CE, Sennhauser FH. The Yentl syndrome in childhood asthma: risk factors for undertreatment in Swiss children. Pediatr Pulmonol. 1995;19(3):156-60. DOI: 10.1002/ppul.1950190303.
  48. 48. Castro-Rodriguez JA, Holberg CJ, Morgan WJ, Wright AL, Martinez FD. Increased incidence of asthmalike symptoms in girls who become overweight or obese during the school years. Am J Respir Crit Care Med. 2001;163(6):1344-9. DOI: 10.1164/ajrccm.163.6.2006140.
  49. 49. Weiss ST. Obesity: insight into the origins of asthma. Nat Immunol. 2005;6:537-9.
  50. 50. Rupp NT, Guill MF, Brudno DS. Unrecognized exercise-induced bronchospasm in adolescent athletes. Am J Dis Child. 1992;146(8):941-4. DOI: 10.1001/archpedi.1992.02160200063028.
  51. 51. Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, Farooque S, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2008;38(1):19-42. DOI : 10.1111/j.1365-2222.2007.02888.x.
  52. 52. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160. DOI: 10.1111/j.1398-9995.2007.01620.x.
  53. 53. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123-48. DOI: 10.1111/j.1398-9995.2008.01884.x.
  54. 54. Bjorksten B, Clayton T, Ellwood P, Stewart A, Strachan D, ISAAC Phase III Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008;19(2):110-24. DOI: 10.1111/j.1399-3038.2007.00601.x.
  55. 55. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381-7. DOI: 10.1016/j.jaci.2007.03.034.
  56. 56. da Silva CHM, da Silva TE, Morales NMO, Fernandes KP, Pinto RMC. Quality of life in children and adolescents with allergic rhinitis. Braz J Otorhinolaryngol. 2009;75(5):642-9.
  57. 57. Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol. 2003;111(3):491-7. DOI: 10.1067/mai.2003.138.
  58. 58. Strachan D, Sibbald B, Weiland S, Ait-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8(4):161-76. DOI: 10.1111/j.1399-3038.1997.tb00156.x.
  59. 59. Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A, et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy. 2012;42(2):186-207. DOI: 10.1111/j.1365-2222.2011.03891.x.
  60. 60. Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O’Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy. 1993;71(2):121-6.
  61. 61. Keil T, Bockelbrink A, Reich A, Hoffmann U, Kamin W, Forster J, et al. The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol. 2010;21(6):962-9. DOI: 10.1111/j.1399-3038.2010.01046.x.
  62. 62. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic Rhinitis. Lancet. 2011;378(9809):2112-22. DOI: 10.1016/S0140-6736(11)60130-X.
  63. 63. Scadding GK. Optimal management of allergic rhinitis. Arch Dis Child. 2015;100(6):576-82. DOI: 10.1136/archdischild-204-306300.
  64. 64. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61(5):376-82. DOI: 10.1136/thx.2005.042523.
  65. 65. Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007;120(4):863-9. DOI: 10.1016/j.jaci.2007.07.020.
  66. 66. Kim SW, Han DH, Lee SJ, Lee CH, Rhee CS. Bronchial hyperresponsiveness in pediatric rhinitis patients: the difference between allergic and nonallergic rhinitis. Am J Rhinol Allergy. 2013;27(3):e63-8. DOI: 10.2500/ajra.2013.27.3877.
  67. 67. Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569-79. DOI: 10.1111/all.12124.
  68. 68. Anolik R, Nathan RA, Schenkel E, Danzig MR, Gates D, Varghese S. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis. Int Arch Allergy Immunol. 2008;147(4):323-30. DOI: 10.1159/000144040.
  69. 69. Ratner PH, Meltzer EO, Teper A. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2009;73(5):651-7. DOI: 10.1016/j.ijporl.2008.12.025.
  70. 70. Wandalsen GF, Mendes AI, Sole D. Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis. Am J Rhinol Allergy. 2010;24(1):e32-6. DOI: 10.2500/ajra.2010.24.3427.
  71. 71. Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, et al. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(5):497-505. DOI: 10.1016/S1081-1206(10)60477-2.
  72. 72. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105(2):E23. DOI: 10.1542/peds.105.2.e23.
  73. 73. Allen DB, Meltzer EO, Lemanske Jr RF, Philpot EE, Faris MA, Kral KM, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002;23(6):407-13.
  74. 74. Daley-Yates PT, Kunka RL, Yin Y, Andrews SM, Callejas S, Ng C. Bio-availability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol. 2004;60(4):265-8. DOI: 10.1007/s00228-004-0763-y.
  75. 75. Lee LA, Sterling R, Maspero J, Clements D, Ellsworth A, Pedersen S. Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis. J Allergy Clin Immunol Pract. 2014;2(4):421-7. DOI: 10.1016/j. jaip.2014.04.008.
  76. 76. Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102-16. DOI: 10.1111/all.12235.
  77. 77. Anolik R. Mometasone Furoate Nasal Spray With Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(3):264-71. DOI: 10.1016/S1081-1206(10)60452-8.
  78. 78. Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, et al. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Ann Allergy Asthma Immunol. 2006;96(6):851-7. DOI: 10.1016/S1081-1206(10)61349-X.
  79. 79. Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34(2):259-67. DOI: 10.1111/j.1365-2222.2004.01877.x.
  80. 80. Benninger M, Farrar JR, Blaiss M, Chipps B, Ferguson B, Krouse J, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104(1):13-29. DOI: 10.1016/j.anai.2009.11.020.
  81. 81. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006;61(7):855-9. DOI: 10.1111/j.1398-9995.2006.01068.x.
  82. 82. Calderon MA, van Wijk RG, Eichler I, Matricardi PM, Varga EM, Kopp MV, et al. Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol. 2012;23(4):300-6. DOI: 10.1111/j.1399-3038.2012.01313.x.
  83. 83. Santos AF, Borrego LM, Rotirori G, Scadding G, Roberts G. The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice. Clin Transl Allergy. 2015;5(1):2. DOI: 10.1186/s13601-014-0044-5.
  84. 84. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005;128(5):3140-7. DOI: 10.1378/chest.128.5.3140.
  85. 85. Buggiani G, Ricceri F, Lotti T. Atopic dermatitis. Dermatol Ther. 2008;21(2):96-100. DOI: 10.1111/j.1529-8019.2008.00176.x.
  86. 86. Peters AS, Kellberger J, Vogelberg C, Dressel H, Windstetter D, Weinmayr G, et al. Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2010;126(3):590-5.e1-3. DOI: 10.1016/j.jaci.2010.06.020.
  87. 87. Williams HC. Eczema across the world: the missing piece of the jigsaw revealed. J Invest Dermatol. 2011;131(1):12-4. DOI: 10.1038/jid.2010.333.
  88. 88. Ricci G, Bellini F, Dondi A, Patrizi A, Pession A. Atopic dermatitis in adolescence. Dermatol Reports. 2011;4(1):e1. DOI: 10.4081/dr.2012.e1.
  89. 89. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51. DOI: 10.1016/j. jaad.2013.10.010.
  90. 90. Smidesang I, Saunes M, Storrø O, Øien T, Holmen TL, Johnsen R, et al. Atopic dermatitis among 2-year olds; high prevalence, but predominantly mild disease – the PACT study, Norway. Pediatr Dermatol. 2008;25(1):13-8. DOI: 10.1111/j.1525-1470.2007.00574.x.
  91. 91. Dirven-Meijer PC, Glazenburg EJ, Mulder PGH, Oranje AP. Prevalence of atopic dermatitis in children younger than 4 years in a demarcated area in central Netherlands: the West Veluwe Study Group. Br J Dermatol. 2008;158(4):846-7. DOI: 10.1111/j.1365-2133.2007.08407.x.
  92. 92. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008;63(11):1418-27. DOI: 10.1111/j.1398-9995.2008.01880.x.
  93. 93. Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH. The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dermatol. 2010;22(2):180-5. DOI: 10.5021/ad.2010.22.2.180.
  94. 94. Kemmet D, Tidman MJ. The influence of the menstrual cycle and pregnancy on atopic dermatitis. Br J Dermatol. 1991;125(1):59-61. DOI: 10.1111/j.1365-2133.1991.tb06041.x.
  95. 95. Braun-Falco O, Plewig G, Wolf HH, et al. Dermatology 2002;501:504.
  96. 96. Darabi K, Hostetler SG, Bechtel MA, Zirwas M. The role of Malassezia in atopic dermatitis affected the head and the neck of adults. J Am Acad Dermatol. 2009;60(1):125-36. DOI: 10.1016/j. jaad.2008.07.058.
  97. 97. Slattery MJ, Essex MJ. Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents. J Psychiatr Res. 2011;45(6):788-95. DOI: 10.1016/j. jpsychires.2010.11.003.
  98. 98. Crespo JF, Pascual C, Burks AW, Helm RM, Esteban MM. Frequency of food allergy in a pediatric population from Spain. Pediatr Allergy Immunol. 1995;6(1):39-43. DOI: 10.1111/j.1399-3038.1995.tb00256.x.
  99. 99. Niggemann B, Sielaff B, Beyer K, Binder C, Wahn U. Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clin Exp Allergy. 1999;29(1):91-6. DOI: 10.1046/j.1365-2222.1999.00454.x.
  100. 100. Sicherer SH, Munoz-Furlong A, Burks W, Sampson HA. Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol. 1999;103(4):559-62. DOI: 10.1016/s0091-6749(99)70224-1.
  101. 101. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW. Cohort study of peanut and tree nut sensitization by age of 4years. BMJ. 1996;313(7056):514-7. DOI: 10.1136/bmj.313.7056.514.
  102. 102. Madsen C. Prevalence of food allergy/intolerance in Europe. Environ Toxicol Pharmacol. 1997;4(1-2):163-7. DOI: 10.1016/s1382-6689(97)10058-8.
  103. 103. Roehr CC, Edenharter G, Reimann S, Ehlers I, Worm M, Zuberbier T, et al. Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy. 2004;34(10):1534-41. DOI: 10.1111/j.1365-2222.2004.02080.x.
  104. 104. Eggesbo M, Halvorsen R, Tambs K, Botten G. Prevalence of parentally perceived adverse reactions to food in young children. Pediatr Allergy Immunol. 1999;10(2):122-32. DOI: 10.1034/j.1399-3038.1999.00022.x.
  105. 105. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food intolerance. Lancet. 1994;343(8906):1127-30. DOI: 10.1016/s0140-6736(94)90234-8.
  106. 106. Host A. Adverse reactions to foods: epidemiology and risk factors. Pediatr Allergy Immunol. 1995;6 (Suppl 8):20-8.
  107. 107. Høst A, Halken S. A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological hypersensitivity reaction. Allergy. 1990;45(8):587-96. DOI: 10.1111/j.1398-9995.1990.tb00944.x.
  108. 108. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first three years of life. Pediatrics. 1987;79(5):683-8.
  109. 109. Sloan AE, Powers MA. A perspective on popular perception of adverse reactions to foods. J Allergy Clin Immunol. 1986;78(1 Pt 2):127-33. DOI: 10.1016/0091-6749(86)90002-3.
  110. 110. Eggesbø M, Botten G, Stigum H. Restricted diets in children with reactions to milk and egg perceived by their parents. J Pediatr. 2001;139(4):583-7. DOI: 10.1067/mpd.2001.117067.
  111. 111. Niggemann B, Grüber C. Side-effects of complementary and alternative medicine. Allergy. 2003;58(8):707-16. DOI: 10.1034/j.1398-9995.2003.00219.x.
  112. 112. Henriksen C, Eggesbø M, Halvorsen R, Botten G. Nutrient intake among two-year-old children on cows’ milk-restricted diets. Acta Paediatr. 2000;89(3):272-8.
  113. 113. Roesler TA, Barry PC, Bock SA. Factitious food allergy and failure to thrive. Arch Pediatr Adolesc Med. 1994;148(11):1150-5. DOI: 10.1001/archpedi.1994.02170110036006.
  114. 114. Davidovits M, Levy Y, Avramovitz T, Eisenstein B. Calcium-deficiency rickets in a four-year-old boy with milk allergy. J Pediatr. 1993;122(2):249-51. DOI: 10.1016/s0022-3476(06)80124-1.
  115. 115. Robertson DAF, Ayers RCS, Smith CL, Wright R. Adverse consequences arising from misdiagnosing food allergy. BMJ. 1988;297:719-20. DOI: 10.1136/bmj.297.6650.719-a.
  116. 116. Schrander JJ, van den Bogart JP, Forget PP, Schrander-Stumpel CT, Kuijten RH, Kester AD. Cow’s milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. Eur J Pediatr. 1993;152(8):640-4. DOI: 10.1007/BF01955238.
  117. 117. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327:380-4. DOI: 10.1056/NEJM199208063270603.
  118. 118. Yunginger JW, Sweeney KG, Sturner WQ, Giannandrea LA, Teigland JD, Bray M, et al. Fatal food-induced anaphylaxis. JAMA. 1988;260(10):1450-2.
  119. 119. Macdougall CF, Cant AJ, Clover AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002;86(4):236-9. DOI: 10.1136/adc.86.4.236.
  120. 120. Niggemann B, Wahn U, Sampson HA. Proposals for standardization of oral food challenge tests in infants and children. Pediatr Allergy Immunol. 1994;5(1):11-3. DOI: 10.1111/j.1399-3038.1994. tb00212.x.
  121. 121. Brett GM, Bull VJ, Morgan MR. Identification of hidden allergens within foods. Allergy. 1998;53(46 Suppl):109-10. DOI: 10.1111/j.1398-9995.1998.tb04977.x.
  122. 122. White MV, Silvia S, Muniz R, Herrem C, Hogue SL. Prevalence and triggers of anaphylactic events in schools. Allergy Asthma Proc. 2017;38(4):286-93. DOI: 10.2500/aap.2017.38.4066.
DOI: https://doi.org/10.2478/rjr-2022-0009 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Language: English
Page range: 53 - 61
Submitted on: Oct 18, 2021
Accepted on: Nov 17, 2021
Published on: Apr 30, 2022
Published by: Romanian Rhinologic Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Ali Bayram, Nuray Bayar Muluk, Cemal Cingi, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.